Study of Tiny Blood Particles During CAR-T Therapy
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study is for people getting CAR-T cell therapy, a type of cancer treatment that uses your own immune cells. Researchers want to understand a rare side effect called neurotoxicity by looking at tiny particles in your blood called extracellular vesicles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your doctor has recommended CAR-T cell therapy for you.
- You are covered by a social security system.
- You are willing to sign a consent form to participate.
- You are not pregnant or breastfeeding.
- You are not under legal protection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses blood tests and brain imaging to better understand and predict nerve-system side effects that can happen after CAR T-cell treatment. It may help doctors spot people at higher risk sooner and guide safer care.
This study uses a simple iPad test to check for thinking problems that can happen after CAR-T cell therapy. It aims to catch these issues early so they can be managed better.
This study looks at a biological process called trogocytosis (when immune cells swap pieces of their outer coating) to see if it can help predict how well CAR-T cell therapy works for people with a type of lymphoma called diffuse large B-cell lymphoma.
This study looks at tiny particles called extracellular vesicles in the blood of people receiving CAR-T cell therapy for certain blood cancers. It may help researchers understand how these particles affect treatment outcomes.
This study looks at how your immune system responds to CAR-T cell therapy, a treatment that uses your own immune cells to fight certain cancers. By participating, you help researchers learn more about how this therapy affects the body, which could improve care for future patients.
This study watches patients getting CAR-T cell therapy to see if it affects brain function, thinking, or memory. It aims to find out how common these effects are and help doctors manage them.
Hear when a new Immune Effector Cell Associated Neurotoxicity Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.